Senhwa Biosciences, Inc. (6492.TWO)
TWD 35.1
(-9.88%)
TWD 35.1
(-9.88%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 46.17 Million TWD | 12.83% |
| 2022 | 40.92 Million TWD | -55.73% |
| 2021 | 92.44 Million TWD | 33.99% |
| 2020 | 68.99 Million TWD | 121.6% |
| 2019 | 31.13 Million TWD | -14.82% |
| 2018 | 36.55 Million TWD | -36.8% |
| 2017 | 57.83 Million TWD | 177.82% |
| 2016 | 20.81 Million TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 34.74 Million TWD | -4.89% |
| 2024 Q1 | 36.53 Million TWD | -20.88% |
| 2023 Q3 | 26.32 Million TWD | 6.52% |
| 2023 Q4 | 46.17 Million TWD | 75.39% |
| 2023 FY | 46.17 Million TWD | 12.83% |
| 2023 Q2 | 24.71 Million TWD | 7.17% |
| 2023 Q1 | 23.06 Million TWD | -43.65% |
| 2022 Q3 | 45.06 Million TWD | 48.57% |
| 2022 Q2 | 30.33 Million TWD | -38.39% |
| 2022 Q1 | 49.23 Million TWD | -46.74% |
| 2022 Q4 | 40.92 Million TWD | -9.19% |
| 2021 Q3 | 82.94 Million TWD | 0.0% |
| 2021 Q4 | 92.44 Million TWD | 11.46% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -560.209% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 92.086% |
| Level Biotechnology Inc. | 273.2 Million TWD | 83.099% |
| Sagittarius Life Science Corp | 137.82 Million TWD | 66.497% |
| NeoCore Technology Co., Ltd. | 197.47 Million TWD | 76.617% |
| TaiMed Biologics Inc. | 1.32 Billion TWD | 96.523% |
| GlycoNex Incorporation | 276.39 Million TWD | 83.294% |
| VBI | 21.25 Million TWD | -117.284% |
| GeneReach Biotechnology Corp. | 313.7 Million TWD | 85.281% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 91.028% |
| SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -117.54% |
| Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 87.464% |
| Visgeneer Inc. | 185.6 Million TWD | 75.122% |
| Mycenax Biotech Inc. | 1.32 Billion TWD | 96.51% |
| Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 93.7% |
| G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | 61.476% |
| Neith Corporation | 17.43 Million TWD | -164.871% |
| Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 97.944% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -597.718% |
| Enimmune corporation | 173.46 Million TWD | 73.38% |
| TaiRx, Inc. | 60.62 Million TWD | 23.835% |
| CHO Pharma, Inc. | 110.83 Million TWD | 58.338% |
| EirGenix Inc. | 1.14 Billion TWD | 95.968% |
| BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | 58.765% |
| Sunny Pharmtech Inc. | 512.43 Million TWD | 90.989% |
| Lin BioScience, Inc. | 167.73 Million TWD | 72.471% |
| BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | 50.728% |
| Feng Chi Biotech Corp. | 63.03 Million TWD | 26.746% |
| Bio Preventive Medicine Corp. | 124.72 Million TWD | 62.98% |
| Lukas Biomedical Inc. | 161.05 Million TWD | 71.33% |
| RBC Bioscience Corporation | 513.08 Million TWD | 91.0% |
| BiOptic Inc. | 170.56 Million TWD | 72.928% |
| BRIM Biotechnology, Inc. | 42.15 Million TWD | -9.528% |
| Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -98.559% |
| Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -72.211% |
| Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 95.262% |
| Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -479.215% |
| NaviFUS Corp. | 53.4 Million TWD | 13.532% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 90.41% |
| Sinew Pharma Inc. | 39.71 Million TWD | -16.269% |
| Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | 20.441% |
| Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 87.331% |
| Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | 79.721% |
| AP Biosciences Inc | 106.65 Million TWD | 56.704% |
| Medigen Biotechnology Corp. | 3.53 Billion TWD | 98.692% |
| 3D Global Biotech Inc. | 30.68 Million TWD | -50.5% |
| Pharmosa Biopharm Inc. | 195.99 Million TWD | 76.44% |
| Intech Biopharm Corporation | 1.54 Billion TWD | 97.008% |
| Oneness Biotech Co., Ltd. | 866.42 Million TWD | 94.671% |
| Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -397.79% |
| TWi Biotechnology, Inc. | 55.81 Million TWD | 17.268% |
| Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | 80.179% |
| TCI GENE Inc. | 155.54 Million TWD | 70.315% |
| MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -81.022% |
| Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 85.942% |
| NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | 28.838% |
| PharmaEngine, Inc. | 91 Million TWD | 49.262% |
| Savior Lifetec Corporation | 457.95 Million TWD | 89.917% |
| TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | 58.378% |
| OBI Pharma, Inc. | 650.44 Million TWD | 92.901% |
| Meribank Biotech Co., Ltd | 390.81 Million TWD | 88.185% |
| Acepodia, Inc. | 384.47 Million TWD | 87.99% |
| Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | 46.028% |